MYOVANT SCIENCES LTD's ticker is MYOV and the CUSIP is G637AM102. A total of 93 filers reported holding MYOVANT SCIENCES LTD in Q2 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $22,410,499 | +51.8% | 831,250 | +1.1% | 0.00% | – |
| Q3 2022 | $14,760,000 | +38.2% | 821,841 | -4.3% | 0.00% | – |
| Q2 2022 | $10,679,000 | +2.4% | 859,155 | +9.7% | 0.00% | – |
| Q1 2022 | $10,431,000 | -15.0% | 783,037 | -0.6% | 0.00% | – |
| Q4 2021 | $12,272,000 | -31.7% | 788,160 | -1.5% | 0.00% | – |
| Q3 2021 | $17,965,000 | +1.9% | 800,545 | +3.4% | 0.00% | – |
| Q2 2021 | $17,631,000 | +12.9% | 774,317 | +2.1% | 0.00% | – |
| Q1 2021 | $15,612,000 | +281.1% | 758,579 | +411.5% | 0.00% | – |
| Q4 2020 | $4,097,000 | +34.7% | 148,318 | -31.5% | 0.00% | – |
| Q3 2020 | $3,041,000 | +3.6% | 216,463 | +52.1% | 0.00% | – |
| Q2 2020 | $2,934,000 | +187.6% | 142,308 | +5.3% | 0.00% | – |
| Q1 2020 | $1,020,000 | -49.6% | 135,197 | +3.7% | 0.00% | – |
| Q4 2019 | $2,022,000 | +219.9% | 130,368 | +7.2% | 0.00% | – |
| Q3 2019 | $632,000 | -43.5% | 121,572 | -1.8% | 0.00% | – |
| Q2 2019 | $1,119,000 | +217.9% | 123,756 | +313.1% | 0.00% | – |
| Q1 2017 | $352,000 | -0.6% | 29,958 | +5.0% | 0.00% | – |
| Q4 2016 | $354,000 | – | 28,518 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| VitalStone Financial, LLC | 15 | $0 | 0.00% |
| HUNTINGTON NATIONAL BANK | 1 | $27 | 0.00% |